French national cancer institute chief to head Afssaps
This article was originally published in SRA
Executive Summary
Dominique Maraninchi, currently head of France's national cancer institute (INC), is to head up the country's health products regulator, Afssaps, a French government source, who wished to remain anonymous, has told Regulatory Affairs Medtech's sister publication Scrip Intelligence. Afssaps is to have two directors, although it is unclear who will join Professor Maraninchi at the helm
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.